STOCKSCREENR

0T6G.L

LSE

Q32 Bio Inc.

$5.39+0.01(+0.19%)Mkt Cap: $66.29M

Key Stats

Market Cap

$66.29M

P/E Ratio

-112.29

EPS

$-0.05

Dividend Yield

0.00%

52-Week Range

$0.46 — $5.62

Volume

39

Avg Volume

2.63K

Beta

-1.02

Price Alerts for 0T6G.L

Get alerted when 0T6G.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-112.29

Forward P/E

—

PEG Ratio

0.01

P/S (TTM)

1.34

P/B (TTM)

1.75

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

16.30%

ROA (TTM)

0.48%

ROIC

—

Gross Margin

1.00%

Operating Margin

0.31%

Net Margin

—

Debt/Equity

0.27

Current Ratio

4.85

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-2.66%

EPS Growth (5Y)

-3.69%

Sales Growth (3Y)

-0.99%

Sales Growth (5Y)

+1.84%

EPS Est (This Year)

$-2.60

EPS Est (Next Year)

$-4.80

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$3.84

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

12.30M

Float

4.65M

Free Float %

37.82%

About

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Country

US

Exchange

LSE

IPO Date

2018-10-04

Employees

42

CEO

Jodie Pope Morrison

Index Membership

—

Website

https://www.q32bio.com

Q32 Bio Inc. (0T6G.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $66.29M, a P/E ratio of -112.29, 0T6G.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0T6G.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

SDEV

Stablecoin Development Corp.

$1.24

-2.36%

$33.02M

0DOL.L

Biofrontera AG

$2.50

+1.63%

$111.43M

KYNB

Kyntra Bio, Inc.

$7.27

+3.12%

$29.42M

LFMD

LifeMD, Inc.

$4.68

+5.64%

$224.52M

0IL8.L

Kyntra Bio, Inc.

$7.23

+2.40%

$29.21M

0LOV.L

Verastem, Inc.

$5.42

+2.07%

$328.12M

Frequently Asked Questions

What is Q32 Bio Inc.'s P/E ratio?

Q32 Bio Inc. (0T6G.L) has a trailing twelve-month (TTM) P/E ratio of -112.29. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Q32 Bio Inc. pay a dividend?

No, Q32 Bio Inc. (0T6G.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Q32 Bio Inc.'s market cap?

Q32 Bio Inc. (0T6G.L) has a market capitalization of $66.29 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.